Rottendorf Pharma
Jennifer Demandt began their work experience in 2016 as a PHD Student at Westfälische Wilhelms-Universität Münster. Jennifer worked in this role until September 2019.
In October 2019, Jennifer joined Rottendorf Pharma as a Scientist Analytical Technology. Jennifer held this position until June 2021.
Jennifer then transitioned to the role of Team Leader Analytical Services at Rottendorf Pharma in June 2021, where they are currently employed.
Jennifer Demandt earned their Bachelor of Science in Chemie from the University of Münster from 2011 to 2014. Jennifer then pursued a Master of Science in Chemie from the same institution from 2014 to 2016. Jennifer completed their education by obtaining a Doctor of Natural Sciences (Dr. rer. nat.) in Analytical Chemistry from the University of Münster from 2016 to 2019.
Rottendorf Pharma
1 followers
A first-class contract development and manufacturing organization (CDMO), Rottendorf Pharma has been manufacturing, packaging, developing formulations and analytical methods for solid oral dosage forms for the global pharmaceutical industry for more than 85 years. The company produces more than 600 originator and generic drug products annually for big, small, virtual, and global pharmaceutical and biotechnology companies. Rottendorf Pharma operates by the philosophy of Total Process Ownership (TPO) and Total Technological Mastering (TTM), in which we work as an extension of clients' organizations. Therefore leveraging our expertise to optimize solid dosage form production for our customers' benefit. Rottendorf Pharma has neither their own product brands in the market nor holds any product licenses, and therefore is never in competition with their clients.